ANIX · Company research
Anixa Biosciences, Inc. (ANIX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc (NASDAQ:ANIX) Stock Has Consensus Target Price of $8.00 - MarketBeat | Anixa Biosciences Inc (NASDAQ:ANIX) Stock Has Consensus Target Price of $8.00 MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Four ovarian cancer patients lived over a year after Anixa's experimental treatment. - Stock Titan | Four ovarian cancer patients lived over a year after Anixa's experimental treatment. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| Several patients in an ovarian cancer trial survived over a year after immune-cell treatment; one exceeded two years. - Stock Titan | Several patients in an ovarian cancer trial survived over a year after immune-cell treatment; one exceeded two years. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Four ovarian cancer patients survived over a year after immune-cell treatment; one lived beyond two years. - Stock Titan | Four ovarian cancer patients survived over a year after immune-cell treatment; one lived beyond two years. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| After buying 5,500 shares, Anixa Biosciences (ANIX) CFO holds 50,000 shares directly. - Stock Titan | After buying 5,500 shares, Anixa Biosciences (ANIX) CFO holds 50,000 shares directly. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Michael Catelani Buys 5,500 Shares - MarketBeat | Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Michael Catelani Buys 5,500 Shares MarketBeat | View source ↗ | MarketBeat | Sep 30, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences director buys $13,799 in ANIX stock - Investing.com | Anixa Biosciences director buys $13,799 in ANIX stock Investing.com | View source ↗ | Investing.com | Sep 28, 2026 | neutral | 0 | 0.6 |
| Insider Buying: Anixa Biosciences (NASDAQ:ANIX) CEO Buys $19,460.00 in Stock - MarketBeat | Insider Buying: Anixa Biosciences (NASDAQ:ANIX) CEO Buys $19,460.00 in Stock MarketBeat | View source ↗ | MarketBeat | Sep 28, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Arnold Baskies Purchases 5,000 Shares - MarketBeat | Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Arnold Baskies Purchases 5,000 Shares MarketBeat | View source ↗ | MarketBeat | Sep 28, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences (ANIX) CEO buys shares, bringing his direct holdings to 672,000 - Stock Titan | Anixa Biosciences (ANIX) CEO buys shares, bringing his direct holdings to 672,000 Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Director Arnold M. Baskies holds 140,572 Anixa Biosciences (ANIX) shares after his purchase. - Stock Titan | Director Arnold M. Baskies holds 140,572 Anixa Biosciences (ANIX) shares after his purchase. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Anixa to present cancer data: longest survival is about 28 months - Stock Titan | Anixa to present cancer data: longest survival is about 28 months Stock Titan | View source ↗ | Stock Titan | Aug 18, 2026 | neutral | 0 | 0.6 |
| Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance | Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Jul 22, 2026 | neutral | 0 | 0.6 |
| ANIX Forecast — Price Target — Prediction for 2027 - TradingView | ANIX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Add ANIX Stock to Your Portfolio Now - Yahoo Finance | Here's Why You Should Add ANIX Stock to Your Portfolio Now Yahoo Finance | View source ↗ | Yahoo Finance | Jun 25, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Add ANIX Stock to Your Portfolio Now - TradingView | Here's Why You Should Add ANIX Stock to Your Portfolio Now TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Executive Officer of $ANIX Buys 21,000 Shares - Quiver Quantitative | Insider Purchase: Chief Executive Officer of $ANIX Buys 21,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 16, 2026 | neutral | 0 | 0.6 |
| We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate - Simply Wall Street | We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate Simply Wall Street | View source ↗ | Simply Wall Street | Mar 25, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 7, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.